Isoflavones and bone health

Menopause

Volumn 11, Issue 3, 2004, Pages 239-241

  Morin, Suzanne ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; DAIDZEIN; ESTRADIOL; ESTROGEN RECEPTOR; GENISTEIN; ISOFLAVONE DERIVATIVE; LIGNAN DERIVATIVE; PHYTOESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; PLANT MEDICINAL PRODUCT; SOYBEAN PROTEIN;

BINDING AFFINITY; BODY MASS; BONE DENSITY; BONE GROWTH; BONE MASS; BONE MINERAL; CALCIUM INTAKE; CELL DIFFERENTIATION; DIET; EDITORIAL; FEMALE; HUMAN; LYMPHOCYTOPENIA; MENOPAUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; RAT; RISK ASSESSMENT; TRABECULAR BONE; VERTEBRA FRACTURE; NOTE; PHYTOTHERAPY; POSTMENOPAUSE OSTEOPOROSIS;

FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOESTROGENS; PHYTOTHERAPY; PLANT PREPARATIONS; SOYBEAN PROTEINS;

EID: 4043123469     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000125650.82154.B5     Document Type: Editorial

References (11)

1. The roles of isoflavones in menopausal health: consensus opinion of the North American Menopausal Society. Menopause 2000;7:215-229.
2. Writing Group for the Women's Health Initiative Investigations. Risks and Benefits of oestrogens plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative controlled trial. JAMA 2002;288:321-333.
3. Migliaccio S, Anderson JJB. Isoflavones and skeletal health: are these molecules ready for clinical application?. Osteoporos Int 2003;14:361-368.
4. Heim M, Frank O, Kampmann G, et al. The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. Endocrinology 2004;145:848-859.
5. Ho SC, Chan SG, Yi Q, et al. Soy intake and the maintenance of peak bone mass in Hong-Kong Chinese women. J Bone Miner Res 2001;16:1362-1366.
6. Mei J, Yeung SSC, Kung AWC. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 2001;86:5217-5221.
7. Fitzpatrick LA, Vincent A, Oberg A. Soy isoflavones: Increased bone turnover and less bone loss at the hip in postmenopausal women [Abstract SA 363]. ASBMR 25th annual meeting, Minneapolis, MN; September 19-23, 2003.
8. Chen Y-M, Ho S, Lam S, et al. Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: A double-blind, randomized, controlled trial menopause. Menopause 2004;11:246-254.
9. Chen Y-M, Ho S, Lam S, et al. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: A double-blind, randomized controlled trial. J Clin Endocrinol Metab 2003;88:4740-4747.
10. Brown JP, Josse RG. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002;167(10 Suppl):S13-S20.
11. Alexandersen P, Toussaint A, Christiansen C, et al. Ipriflavone in the treatment of postmenopausal osteoporosis. JAMA 2001;285:1482-1488.